slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 204,571-204,600
Pages 10,126
Rows per page 30
Component
204,571-204,600 of 303,780
37
The slide uses a 3x3 grid layout to present financial metrics.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations Beat · Financials1 hit
38
Shows strong revenue growth (+73%) alongside stable adjusted EBITDA.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations Beat · Financials1 hit
41
Uses donut charts to show shifts in revenue composition.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations Beat · Financials1 hit
42
Uses a waterfall-like logic to explain EBITDA growth drivers across two time periods.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations Beat · Financials1 hit
43
Includes footnotes regarding accounting standards and scope of contribution.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations Beat · Financials1 hit
44
The image is a detail from Sandro Botticelli's 'Primavera'.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
45
Includes detailed footnotes regarding valuation, share pools, and ownership calculations.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
46
The slide highlights a 'tontine-style' incentive structure for SPAC shareholders.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
47
The chart highlights Lanvin Group's 27.9% CAGR compared to a peer median of 8.3%.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
48
Includes median lines for peer group; highlights Lanvin Group valuation at deal vs with bonus shares.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
50
The slide is located in the appendix section of the pitch deck.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
54
The slide uses horizontal bar charts to compare current revenue figures of specific business units against larger industry players.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
56
Standard legal disclaimer slide for a SPAC transaction.Lanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
57
Lanvin | Investor Presentation Deck | 58 slidesLanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
58
Lanvin | Investor Presentation Deck | 58 slidesLanvin | Investor Presentation Deck | 58 slides · Lanvin Group
Pitch deck Investor relations 1 hit
01
Larimar Therapeutics | Investor Presentation Deck | 32 slidesLarimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
02
Larimar Therapeutics | Investor Presentation Deck | 32 slidesLarimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
03
Larimar Therapeutics | Investor Presentation Deck | 32 slidesLarimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Executive Summary1 hit
04
The slide uses a timeline framework to demonstrate the longevity of IP protection.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
05
The slide uses a medical context to establish the urgency and market need for a new therapy.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide outlines a 28-day treatment period with daily administration, targeting Friedreich's ataxia patients.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Roadmap1 hit
08
FA likely refers to Friedreich's Ataxia; FXN refers to frataxin protein.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
09
The slide uses a process flow diagram to show the relationship between SAD and MAD trials.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
10
The slide details the dosing schedule (13 days) and specific sampling days for buccal cells, skin, and platelets across three cohorts with different dosages.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
11
The slide displays two dot plots with error bars representing median and 25th/75th percentiles for different dose cohorts over time.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Hypothesis Test1 hit
14
The slide uses a horizontal layout with four distinct trial descriptions, each paired with an icon.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
15
The slide uses a simple three-row layout to summarize the drug's purpose, current data status, and future milestones.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
16
Larimar Therapeutics | Investor Presentation Deck | 32 slidesLarimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
17
Larimar Therapeutics | Investor Presentation Deck | 32 slidesLarimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
18
Larimar Therapeutics | Investor Presentation Deck | 32 slidesLarimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit